Trishal Boodhna
Haywards Heath, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Subcutaneous foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's disease (aPD): societal cost impact analysis for the UK, France, Germany, Spain, and Canada.
Journal: Journal of medical economics
Published: April 28, 2026
Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's disease (aPD): demonstration of savings from a societal perspective in the UK.
Journal: Journal of medical economics
Published: October 07, 2025
Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's Disease (aPD): demonstration of savings from a societal perspective in the UK.
Journal: Journal of medical economics
Published: September 10, 2024
Early Budget Impact Analysis of Artificial Intelligence to Support the Review of Radiographic Examinations for Suspected Fractures in National Health Service Emergency Departments.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: July 18, 2024
Illness perceptions in people newly diagnosed with glaucoma and ocular hypertension.
Journal: The British journal of ophthalmology
Published: December 21, 2018
Eradicating primary congenital glaucoma from Saudi Arabia: The case for a national screening program.
Journal: Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
Published: November 04, 2016
More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England.
Journal: BMC health services research
Published: May 24, 2016
Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data.
Journal: Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)
Published: September 05, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026